这就像生活在一个定时炸弹中——一项关于患者及其家人与高级别神经胶质瘤复发相关经历的定性研究。

IF 2.5 Q2 CLINICAL NEUROLOGY
Neuro-oncology practice Pub Date : 2025-02-28 eCollection Date: 2025-08-01 DOI:10.1093/nop/npaf026
Helle Sorensen von Essen, Karina Dahl Steffensen, Frantz Rom Poulsen, Karin Piil
{"title":"这就像生活在一个定时炸弹中——一项关于患者及其家人与高级别神经胶质瘤复发相关经历的定性研究。","authors":"Helle Sorensen von Essen, Karina Dahl Steffensen, Frantz Rom Poulsen, Karin Piil","doi":"10.1093/nop/npaf026","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>High-grade gliomas (HGG) are the most aggressive and infiltrative subtype of primary brain tumors. The average survival rate from diagnosis is less than 2 years, and all patients eventually experience a recurrence. However, our understanding of patients' and their families' experiences and coping mechanisms concerning the inevitable recurrence remains limited. This qualitative study explored how patients with HGG and their close family members experience and cope with their fear of recurrence and the diagnosis of HGG recurrence.</p><p><strong>Methods: </strong>Semistructured individual interviews were conducted with patients with HGG and their family members. Following an inductive phenomenological hermeneutical approach, the interviews were coded, and the findings were divided into themes.</p><p><strong>Results: </strong>The study included 15 patients and 14 family members between the ages of 22 and 79. We identified 3 interrelated themes illustrating the complex experiences related to an HGG recurrence. Theme I, <i>Navigating the fear of recurrence</i>, describes experiences and coping mechanisms during the disease trajectory. Theme II, <i>Facing reality and preparing for death</i> and Theme III, <i>Redefining hope in the era of recurrence</i>, illustrate experiences related to the recurrence diagnosis and redefinition of hopes for the future.</p><p><strong>Conclusion: </strong>Fear of recurrence is prominent in patients with HGG and their families, and the recurrence diagnosis triggers thoughts about death and the end-of-life phase. This new knowledge can be used to tailor support to patients and family members during the disease trajectory and personalize advance care planning consultations.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"12 4","pages":"723-731"},"PeriodicalIF":2.5000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349762/pdf/","citationCount":"0","resultStr":"{\"title\":\"<i>It's like living with a ticking time bomb</i>-A qualitative study about patients' and their families' experiences related to the recurrence of a high-grade glioma.\",\"authors\":\"Helle Sorensen von Essen, Karina Dahl Steffensen, Frantz Rom Poulsen, Karin Piil\",\"doi\":\"10.1093/nop/npaf026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>High-grade gliomas (HGG) are the most aggressive and infiltrative subtype of primary brain tumors. The average survival rate from diagnosis is less than 2 years, and all patients eventually experience a recurrence. However, our understanding of patients' and their families' experiences and coping mechanisms concerning the inevitable recurrence remains limited. This qualitative study explored how patients with HGG and their close family members experience and cope with their fear of recurrence and the diagnosis of HGG recurrence.</p><p><strong>Methods: </strong>Semistructured individual interviews were conducted with patients with HGG and their family members. Following an inductive phenomenological hermeneutical approach, the interviews were coded, and the findings were divided into themes.</p><p><strong>Results: </strong>The study included 15 patients and 14 family members between the ages of 22 and 79. We identified 3 interrelated themes illustrating the complex experiences related to an HGG recurrence. Theme I, <i>Navigating the fear of recurrence</i>, describes experiences and coping mechanisms during the disease trajectory. Theme II, <i>Facing reality and preparing for death</i> and Theme III, <i>Redefining hope in the era of recurrence</i>, illustrate experiences related to the recurrence diagnosis and redefinition of hopes for the future.</p><p><strong>Conclusion: </strong>Fear of recurrence is prominent in patients with HGG and their families, and the recurrence diagnosis triggers thoughts about death and the end-of-life phase. This new knowledge can be used to tailor support to patients and family members during the disease trajectory and personalize advance care planning consultations.</p>\",\"PeriodicalId\":19234,\"journal\":{\"name\":\"Neuro-oncology practice\",\"volume\":\"12 4\",\"pages\":\"723-731\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349762/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro-oncology practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/nop/npaf026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npaf026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:高级别胶质瘤(High-grade gliomas, HGG)是原发性脑肿瘤中最具侵袭性和浸润性的亚型。诊断后的平均生存率不到2年,所有患者最终都会复发。然而,我们对患者及其家属关于不可避免的复发的经历和应对机制的了解仍然有限。本定性研究探讨HGG患者及其近亲属如何体验和应对他们对复发的恐惧以及HGG复发的诊断。方法:对HGG患者及其家属进行半结构化的个人访谈。遵循归纳现象学解释学方法,访谈被编码,调查结果被划分为主题。结果:纳入15例患者及14例家庭成员,年龄22 ~ 79岁。我们确定了3个相互关联的主题,说明了与HGG复发相关的复杂经历。主题一,引导对复发的恐惧,描述了疾病轨迹中的经历和应对机制。主题二“面对现实和为死亡做准备”和主题三“重新定义复发时代的希望”阐述了与复发诊断和重新定义对未来的希望有关的经验。结论:HGG患者及其家属对复发的恐惧突出,复发诊断引发对死亡和临终阶段的思考。这一新知识可用于在疾病发展过程中为患者和家庭成员提供量身定制的支持,并个性化预先护理计划咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
It's like living with a ticking time bomb-A qualitative study about patients' and their families' experiences related to the recurrence of a high-grade glioma.

Background: High-grade gliomas (HGG) are the most aggressive and infiltrative subtype of primary brain tumors. The average survival rate from diagnosis is less than 2 years, and all patients eventually experience a recurrence. However, our understanding of patients' and their families' experiences and coping mechanisms concerning the inevitable recurrence remains limited. This qualitative study explored how patients with HGG and their close family members experience and cope with their fear of recurrence and the diagnosis of HGG recurrence.

Methods: Semistructured individual interviews were conducted with patients with HGG and their family members. Following an inductive phenomenological hermeneutical approach, the interviews were coded, and the findings were divided into themes.

Results: The study included 15 patients and 14 family members between the ages of 22 and 79. We identified 3 interrelated themes illustrating the complex experiences related to an HGG recurrence. Theme I, Navigating the fear of recurrence, describes experiences and coping mechanisms during the disease trajectory. Theme II, Facing reality and preparing for death and Theme III, Redefining hope in the era of recurrence, illustrate experiences related to the recurrence diagnosis and redefinition of hopes for the future.

Conclusion: Fear of recurrence is prominent in patients with HGG and their families, and the recurrence diagnosis triggers thoughts about death and the end-of-life phase. This new knowledge can be used to tailor support to patients and family members during the disease trajectory and personalize advance care planning consultations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信